Stock Analiz

Candel Therapeutics, Inc. (CADL) stock forecast and price target

Price $6.20 · data as of November 13, 2026

12-month price target

Average target$17.67
Upside / downside+184.9%
Analysts9
ConsensusStrong buy
Low $11.00Average $17.67High $29.00

Gold marker: average target · white marker: today’s price ($6.20)

Analyst ratings

Strong buy 0Buy 10Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.18−34.7%$0
Next fiscal year
ends December 31, 2027
$-1.44−21.6%$10M
Next quarter
ends December 31, 2026
$-0.30−4.8%$0
Quarter after
ends March 31, 2027
$-0.34—$0

Consensus of the analysts covering Candel Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.

Frequently asked questions

What is the Candel Therapeutics stock price target?

The average 12-month target from 9 analysts is $17.67, 184.9% above the current price of $6.20 Targets range from $11.00 to $29.00.

Is Candel Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (10 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Candel Therapeutics expected to earn?

Analysts expect EPS of $-1.18 for the fiscal year ending December 31, 2026 and $-1.44 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.